• Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Tekmira Pharmaceuticals Corp

+ Add to Watchlist

TKMR:US

19.1401 USD 0.1299 0.67%

As of 10:32:21 ET on 10/23/2014.

Snapshot for Tekmira Pharmaceuticals Corp (TKMR)

Open: 19.4600 Day's Range: 18.8501 - 19.6100 Volume: 516,746
Previous Close: 19.2700 52wk Range: 7.1700 - 31.4800 1-Yr Rtn: +121.99%

Stock Chart for TKMR

No chart data available.
  • TKMR:US 19.1500
  • 1D
  • 1M
  • 1Y
19.2700
Interactive TKMR Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for TKMR

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -1.6850
Est. PEG Ratio -
Market Cap (M USD) 425.48
Shares Outstanding (M) 22.08
30 Day Average Volume 5,952,859
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for TKMR

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for TKMR

Tekmira Pharmaceuticals Corporation is a biopharmaceutical company. The Company is focused on advancing RNAi therapeutics and providing its lipid nanoparticle delivery technology to its pharmaceutical partners.

Mark J MurrayPresident/CEOBruce CousinsExec VP:Finance/CFO
Ian MaclachlanExec VP/Chief Technical OfficerMichael J AbramsExec VP/Chief Discovery Officer
More Company Profile & Key Executives for TKMR

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil